Participant education and preparedness in learning personal β‐amyloid PET results: Preliminary findings from the Wisconsin Registry for Alzheimer’s Prevention

Earlier detection of Alzheimer’s disease (AD) coupled with improved accessibility of testing means more adults may learn their biomarker results. To reduce potential negative psychosocial impacts and promote autonomy to act on the AD risk information to make lifestyle and advanced care planning changes, it is imperative that individuals understand the meaning of their results. The Wisconsin Registry for Alzheimer’s Prevention is disclosing β‐amyloid (Aβ) PiB‐PET results to a subsample of cognitively unimpaired older adult participants and assessing the impact of Aβ‐PET disclosure on psychological well‐being, health behaviors, and long‐term planning.